Navigation Links
Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference

BLOOMFIELD, N.J., July 05, 2007 /PRNewswire/ -- Alfacell Corporation today announced that Lawrence A. Kenyon, executive vice president, chief financial officer and corporate secretary, will present an overview of the company's product development programs at 8 a.m. EDT on Thursday, July 12, 2007, at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference in New York.

The audio and slide presentation will be available live at http://www.wsw.com/webcast/ceut6/acel.ob/. A replay will be available at this address within 24 hours of the presentation and will be archived for 90 days.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE(R), is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainties involved in transitioning from concept to product,
'"/>




Page: 1 2

Related medicine technology :

1. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
2. Preclinical Data Show Alfacells Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
3. Researchers Identify Intracellular Pathway of Alfacells Onconase
4. In vivo Study Results Demonstrating Potential of Alfacells Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research
5. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
6. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
7. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
8. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
9. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
10. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
11. The Past, Present and Future of HLA Typing
Post Your Comments:
(Date:3/31/2015)... CHICAGO , March 31, 2015 UHC ... evaluated the use of medical devices based on cost ... high-priced physician preference items (PPIs). The study examined utilization ... a hospital,s supply expenses 1 —at 10 academic medical ... peripheral stents, and cardiac valves. The ...
(Date:3/31/2015)... March 31, 2015 Uroplasty, Inc. (NASDAQ:  UPI) ... completion of their merger. The merger was originally ... all-stock combination creates a new medical device company ... 2015, Cogentix Medical, Inc. will trade on the ... have its U.S. headquarters in Minnetonka, ...
(Date:3/31/2015)... March 31, 2015 /CNW/ - Today, the Honourable Rona Ambrose, ... animal health organizations to discuss the Government of ... (AMR). The roundtable provided an important ... share their priorities and discuss roles and responsibilities in ... their optimal use (also known as antimicrobial stewardship) was ...
Breaking Medicine Technology:UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 2Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 3Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 4
... Calif., Oct. 28 Although Breast Cancer Awareness Month is coming ... health is important throughout the year. What,s more, women age ... their potential risk for breast cancer. Based on the same ... the only FDA-cleared risk assessment tool for non-hereditary breast cancer. ...
... HOERSHOLM, Denmark and SAN DIEGO, California, October ... Mark Wedel, MD, FACP Joins as Vice President and Chief,Medical ... , - Stuart Mackey, JD joins ... Business Development for Proprietary RNA-targeted,Locked Nucleic Acid (LNA) Drug Platform ...
Cached Medicine Technology:Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women 2Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 2Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 4
(Date:3/31/2015)... 31, 2015 Calling all runners, walkers and ... other tick-borne diseases! The first annual “Lyme Walk & Run” ... in Stamford, CT. The event, hosted by Lyme Research ... raise funds to support research and education about Lyme and ... all ages and abilities, will feature 5K and 10K runs ...
(Date:3/31/2015)... Simeon Boyd, UC Davis professor of genetics and ... from the National Institute of Dental and Craniofacial Research ... more than 10 centers in the United States and ... Italy and the United Kingdom, to study craniosynostosis, the ... in infants. , The researchers are members of the ...
(Date:3/31/2015)... Many people, including the ones with physical challenges, ... are only for able-bodied participants. , A new ... to change that thinking. , The program, part ... Sports Expo on Saturday, April 11 (10 a.m. to ... , The event will showcase a wide variety ...
(Date:3/31/2015)... 2015 Medical DNA Labs, LLC, An ... criteria for Laboratory Accreditation by COLA, a national healthcare ... that apply rigid standards of quality in day-to-day operations, ... and pass a rigorous on-site laboratory survey. Medical ... result of a long-term commitment to provide quality service ...
(Date:3/31/2015)... 31, 2015 Indosoft, developer of the Q-Suite ... support in development of their 5.x line. The industry ... been deployed around the world for more than a decade. ... a telephony platform, Q-Suite can fully embrace newer Asterisk features ... center software on Asterisk for more than a decade. The ...
Breaking Medicine News(10 mins):Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 2Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 3Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2
... study by Ceylan, from Turkey evaluated their experience in ... ,Their patient's ages ranged from 5 months to 24 ... circumcisions were performed at various centers or during religious ... ,The group found that the most commonly observed complication ...
... chemicals and industrial effluents in sea and soil could increase your ... was thought to be the most important factor in the development ... does not produce enough insulin - necessary for the body to ... South Korean researchers has shown that people whose bodies are polluted ...
... a lifetime.” , - Herbert Ward //, Child Abuse-The Bitter ... her imaginative world of fairies and angels, while her mom eked ... door jolted her out of her joyous reverie. She hastened to ... in disguise. He locked the door and raped her repeatedly. ...
... and Levitra are the answer to their prayers. But, ... report from Harvard Medical School, these pills offer no ... frequently accompany erectile dysfunction (ED). ,For one ... feeling sexual desire for his partner. If emotional issues ...
... already pressured hospital system would struggle to cope under ... a large-scale emergency, say trauma and emergency specialists.// ... targets for Australasian hospitals, says Dr Anthony Joseph, Director ... ,In the latest Medical Journal of Australia ...
... recently has shown that students who participate in sexual ... those who did not participate in the program. The ... desired positive impact. ,Critics have always ... the Federal government annually on the ‘abstinence-until-marriage education’may not ...
Cached Medicine News:Health News:Child Abuse - When God’s Gifts Land in Devils’ Clutch 2Health News:Child Abuse - When God’s Gifts Land in Devils’ Clutch 3Health News:Can Our Hospitals Cope In A Disaster? 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: